TY - JOUR
T1 - Validation and cross-cultural adjustment of PDQL-questionnaire, Spanish version (Ecuador) (PDQL-EV)
AU - Serrano-Dueñas, Marcos
AU - Martínez-Martín, Pablo
AU - Vaca-Baquero, Verónica
PY - 2004/10
Y1 - 2004/10
N2 - Objective. To validate the Ecuadorian Spanish-language version of the Parkinson's Disease Quality of Life Questionnaire (PDQL-EV). Method. Cross-sectional study of patients with Parkinson's Disease attending a Movement Disorders Clinic. Measures applied. Hoehn and Yahr (HY), Unified Parkinson's Disease Rating Scale (UPDRS-3.0), Schwab and England Scale (SES), Pfeiffer Questionnaire (SPMSQ), Hospital Anxiety and Depression Scale (HADS). PDQ-39 and PDQL-EV were applied, the latter after translation and back translation. Results. The study included 137 patients with an age range of 69.43±10.18 years (mean±SD), duration of illness 5.87±2.58 years, and HY 2.28±0.77. The PDQL-EV internal consistency (Cronbach's alpha) yielded: Parkinson's symptoms (PS) 0.85; systemic symptoms (SS) 0.69; social function (SF) 0.81; and emotional function (EF) 0.78. The correlation between measurements varied from 0.68 (PS-SS) to 0.46 (SS-EF), and total measurement correlation from 0.58 (EF) to 0.74 (PS) (altogether, p<0.0001). The correlation of PDQL with clinical variables was: HY -0.62; UPDRS (subscales 1, 2 and 3) -0.55, -0.76, and -0.48, respectively; SES 0.65; SPMSQ -0.35; HADS-anxiety -0.55; HADS-depression -0.67; and PDQ-39 -0.91 (altogether, p<0.0001). PDQL-EV scores were significantly different (p<0.0001) between moderate and advanced stages, for all domains except for EF (p=0.006). Conclusion. The PDQ-EV has satisfactory internal consistency, and converging and discriminating validity.
AB - Objective. To validate the Ecuadorian Spanish-language version of the Parkinson's Disease Quality of Life Questionnaire (PDQL-EV). Method. Cross-sectional study of patients with Parkinson's Disease attending a Movement Disorders Clinic. Measures applied. Hoehn and Yahr (HY), Unified Parkinson's Disease Rating Scale (UPDRS-3.0), Schwab and England Scale (SES), Pfeiffer Questionnaire (SPMSQ), Hospital Anxiety and Depression Scale (HADS). PDQ-39 and PDQL-EV were applied, the latter after translation and back translation. Results. The study included 137 patients with an age range of 69.43±10.18 years (mean±SD), duration of illness 5.87±2.58 years, and HY 2.28±0.77. The PDQL-EV internal consistency (Cronbach's alpha) yielded: Parkinson's symptoms (PS) 0.85; systemic symptoms (SS) 0.69; social function (SF) 0.81; and emotional function (EF) 0.78. The correlation between measurements varied from 0.68 (PS-SS) to 0.46 (SS-EF), and total measurement correlation from 0.58 (EF) to 0.74 (PS) (altogether, p<0.0001). The correlation of PDQL with clinical variables was: HY -0.62; UPDRS (subscales 1, 2 and 3) -0.55, -0.76, and -0.48, respectively; SES 0.65; SPMSQ -0.35; HADS-anxiety -0.55; HADS-depression -0.67; and PDQ-39 -0.91 (altogether, p<0.0001). PDQL-EV scores were significantly different (p<0.0001) between moderate and advanced stages, for all domains except for EF (p=0.006). Conclusion. The PDQ-EV has satisfactory internal consistency, and converging and discriminating validity.
KW - Cross-cultural validation
KW - Health-related quality of life
KW - Parkinson's disease
KW - PDQL
KW - PDQL-EV
UR - http://www.scopus.com/inward/record.url?scp=4644282276&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2004.05.002
DO - 10.1016/j.parkreldis.2004.05.002
M3 - Article
C2 - 15465402
AN - SCOPUS:4644282276
SN - 1353-8020
VL - 10
SP - 433
EP - 437
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
IS - 7
ER -